Aclaris Therapeutics, Inc Earning Date (ACRS)

USA |NASDAQ |USD

ACRS Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 3, 2022 Jun 2022 $-0.45 - $-0.34
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 3, 2022 Jun 2022 $1.68M - $1.82M

Aclaris Therapeutics, Inc's next earnings date is Wednesday, Aug 3, 2022 for the fiscal quarter ending Jun 2022.

ACRS Earnings Date & History Chart

ACRS Earnings & Revenue Forecast

ACRS Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 6 $-0.45 $-0.47 $-0.40
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 6 $-1.84 $-1.94 $-1.55
Dec 2023 6 $-1.78 $-1.95 $-1.34

ACRS Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Jun 2022 0 / 0 $-0.45 $-0.36 $-0.36
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-1.84 $-1.67 $-1.67
Dec 2023 0 / 0 $-1.78 $-1.60 $-1.53

ACRS Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Jun 2022 6 $1.68M $1.40M $1.90M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 6 $6.76M $5.60M $7.80M
Dec 2023 6 $6.95M $5.60M $8.20M

ACRS Earnings Date & Revenue History

ACRS Earnings History

|
Show More
Show More

ACRS Revenue History

|
Show More
Show More

Aclaris Therapeutics, Inc Next Earnings Date & Report

ACRS Next Earnings Date & Report Preview: Jun 2022 (FQ)

ACRS's next earnings date is Wednesday, Aug 3, 2022 for the fiscal quarter ending Jun 30, 2022.

According to analysts, the average EPS estimation for Aclaris Therapeutics, Inc's next quarterly earnings is $-0.45, with a low EPS estimation of $-0.47, and a high estimation of $-0.40.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.45, the last 2 month trend is $-0.36, and the 3 month trend is $-0.36.

Based on analysts, the average revenue estimation is $1.68M, with a low revenue estimation of $1.40M, and a high estimation of $1.90M.

Aclaris Therapeutics, Inc Previous Earnings Dates & Reports

ACRS Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Aclaris Therapeutics, Inc's previous earnings date was May 5, 2022 for its fiscal quarter ended Mar 31, 2022.

ACRS Previous Earnings Date & Report Recap: Dec 2021 (FY)

Aclaris Therapeutics, Inc's previous annual earnings date was Feb 24, 2022 for its fiscal year ended Dec 31, 2021.

ACRS's earnings per share (EPS) was $-1.63, missing the consensus analysts forecast of $-1.61 by 1.24% , and lower than the previous year's EPS (Dec 2020) by 35.83%.

Revenues were $6.76M, worse than the forecast of $7.05M by -4.10%, and up by 4.30% from previous year's revenue.

The company reported a net income of $-90.86M.

Aclaris Therapeutics, Inc reported a free cash flow of $-52.44M for its fiscal year, compared to $-39.09M a year ago.

The company ended the fiscal year with $693.00K in total debt, a decrease of -93.84% compared to the previous year.